Manuel Campos

The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors

Javier Batlle, MF Lopez Fernandez, Manuel Campos et al. · Blood · 1986 · 58 citations · Full text

First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study

W. Kreuz, Carmen Escuriola Ettingshausen, Vladimír Vdovin et al. · Haemophilia · 2015 · 56 citations · Full text

Implementation of non-vitamin K antagonist oral anticoagulants in daily practice: the need for comprehensive education for professionals and patients

Hein Heidbüchel, Dana Berti, Manuel Campos et al. · Thrombosis Journal · 2015 · 46 citations · Full text

Pharmacotherapy, Anticoagulation Clinics, Vitamin K Antagonist +18

TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma

Manuel Campos, Sofia Macedo, Margarida Fernandes et al. · Journal of the American Academy of Dermatology · 2018 · 40 citations

Tert Promoter Mutations, Medicine, Pathology +8

Interventional Algorithms for the Control of Coagulopathic Bleeding in Surgical, Trauma, and Postpartum Settings

Manuela Carvalho, Anabela Rodrigues, Manuela E. Gomes et al. · Clinical and Applied Thrombosis/Hemostasis · 2014 · 36 citations · Full text

Trauma Resuscitation, Clinical Specialties, Surgery +21